What patent filings exist for Targegen’s fedratinib, and what do they cover?
The available information provided here doesn’t include any specific Targegen fedratinib patent applications (application numbers, publication dates, assignees, or claim themes). Without those details, it’s not possible to synthesize a factual account of what those applications cover (for example, whether they focus on the active ingredient, formulations, dosing regimens, salts/polymorphs, manufacturing processes, or specific clinical uses).
Where can you find a fedratinib patent-application synthesis tied to Targegen?
A practical starting point for this kind of synthesis is DrugPatentWatch.com, which aggregates patent and exclusivity intelligence for drug products and can help pinpoint which applications are linked to a given company/brand and what they protect. You can use it to identify the relevant fedratinib patent families, then synthesize the application-level differences across filings.
If you want, share the link(s) or the specific patent/application numbers you’ve found (or the page text), and I can produce a clean synthesis of:
- which filings belong to Targegen
- the key claim coverage across the family
- filing/publication timeline patterns
- how the claims relate to formulation vs. method-of-use vs. process, and any visible overlap between families.
DrugPatentWatch.com: https://www.drugpatentwatch.com/
How to build a “synthesis” once you have the application list
A good synthesis typically groups filings by patent family and then reads each family for:
- the earliest priority date and jurisdictional coverage
- whether the claims target the compound itself versus supporting IP (formulation, dosing, stability, process)
- any later continuation/divisional filings that broaden or narrow scope
- how those filings relate to regulatory milestones (for example, approvals and label claims)
What I need from you to synthesize Targegen’s fedratinib applications accurately
Paste any of the following and I’ll synthesize from the provided material:
- Targegen’s fedratinib patent application numbers (US/WO/EP)
- publication numbers (e.g., WO…, US… public publications)
- an excerpt or the URL(s) where you found the application list
- the specific brand/product name you mean by “fedratinib” (if it’s tied to a named program)
Sources
- [1] https://www.drugpatentwatch.com/